NIH, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Digestive Diseases and Nutrition, Bethesda, MD, USA.
Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, IL, USA.
Cell Host Microbe. 2017 Nov 8;22(5):589-599. doi: 10.1016/j.chom.2017.10.005.
Mounting evidence indicates that the gut microbiome responds to diet, antibiotics, and other external stimuli with speed and high precision and in ways that impact a variety of metabolic conditions including obesity and non-alcoholic fatty liver disease. Despite a decade of research establishing a strong association between the gut microbiota and obesity in humans, a causal relationship and the underlying mechanism remain outstanding. Several technological and methodological limitations in obesity and microbiome research have made it difficult to establish causality in this complex relationship. Additionally, limited collaborative interaction between microbiome and obesity researchers has delayed progress. Here, we discuss the current status of microbiome research as it relates to understanding obesity from the perspective of both communities, outline the underlying research challenges, and suggest directions to advance the obesity-microbiome field as a whole, with particular emphasis on the development of microbiome-targeted therapies for obesity prevention and treatment.
越来越多的证据表明,肠道微生物组能够快速、高精度地对饮食、抗生素和其他外部刺激做出反应,从而影响多种代谢状况,包括肥胖和非酒精性脂肪肝疾病。尽管十年来的研究已经确定了人类肠道微生物组与肥胖之间存在很强的关联,但因果关系和潜在机制仍然存在。肥胖和微生物组研究中的一些技术和方法学限制使得在这种复杂的关系中很难确定因果关系。此外,微生物组和肥胖研究人员之间有限的合作互动也阻碍了进展。在这里,我们从两个研究领域的角度讨论了与肥胖相关的微生物组研究的现状,概述了潜在的研究挑战,并提出了推动肥胖-微生物组领域整体发展的方向,特别强调了开发针对微生物组的肥胖预防和治疗疗法。